Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis

Clinical Rheumatology

Volumn 26, Issue 8, 2007, Pages 1332-1334

  Jelušić, Marija ^a   Lukić, Ivan Krešimir ^b   Tambić Bukovac, Lana ^a   Dubravčić, Klara ^b   Malčić, Ivan ^a   Rudan, Igor ^b   Batinić, Drago ^b  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Inflammation; Interleukin 18; Juvenile idiopathic arthritis

Indexed keywords

ALPHA 2 GLOBULIN; C REACTIVE PROTEIN; HEMOGLOBIN; INTERLEUKIN 18;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOLOGICAL THERAPY; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOCRIT; HUMAN; INHIBITION KINETICS; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATIENT CARE; PRIORITY JOURNAL; REMISSION; SYNOVIAL FLUID LEVEL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOGLOBINS; HUMANS; INFANT; INTERLEUKIN-18; MALE; SYNOVIAL FLUID;

EID: 34447123133     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0474-0     Document Type: Article

References (13)

1. Sullivan KA (2005) Inflammation in juvenile idiopathic arthritis. Pediatr Clin N Am 52:335-357
2. Mangge H, Vojinovic J, Schauenstein K (2002) Do chemokines spark autoimmunity in juvenile and adult rheumatic disease? Immunobiology 206:459-471
3. Wilkinson N, Jackson G, Gardner-Medwin J (2003) Biologic therapies for juvenile arthritis. Arch Dis Child 88:186-191
4. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435-6443
5. de Benedetti F, Martini A (2005) Targeting the interleukin 6 receptor: A new treatment for systemic juvenile idiopathic arthritis? Arthritis Rheum 52:687-693
6. Gracie JA, Robertson SE, McInnes IB (2003) Interleukin-18. J Leukoc Biol 73:213-224
7. Gracie JA (2004) Interleukin-18 as a potential target in inflammatory arthritis. Clin Exp Immunol 136:402-404
8. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25:1991-1994
9. Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group (2004) Preliminary criteria for clinical remission for selected categories of juvenile idiopathic arthritis. J Rheumatol 31:2290-2294
10. Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Miyawaki S, Amano T, Takeuchi T, Makino H (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 44:550-560
11. Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K (2002) Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: Comment on the article by Kawashima et al. Arthritis Rheum 46:2539-2541
12. Liew FY, McInnes IB (2002) Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 61(Suppl 2):iI100-ii102
13. Scola MP, Thompson SD, Brunner HI, Tsoras MK, Witte D, van Dijk MA, Grom AA, Passo MH, Glass DN (2002) Interferon-y: interleukin 4 ratio and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol 29:369-378